Upjohn's Man In The Hot SeatDavid Woodruff
You can't say John Zabriskie lacks chutzpah. The 54-year-old Merck executive vice-president is tackling what may be the drug industry's toughest job: resuscitating Upjohn. When Zabriskie becomes Upjohn chairman and CEO on Jan. 3, replacing Theodore Cooper, who died of cancer in April, he'll inherit a tangle of thorny problems.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.